News, Deals & Awards

Global law firm Ashurst has advised LGC in relation to the sale of its drug development solutions (DDS) business to Alliance Pharma, a US-based bioanalytical contract research organisation and an Ampersand Capital Partners portfolio company. KKR has also become an equal shareholder in the combined business alongside Ampersand.

The PDF server is offline. Please try after sometime.

Key Contacts

We bring together lawyers of the highest calibre with the technical knowledge, industry experience and regional know-how to provide the incisive advice our clients need.

Keep up to date

Sign up to receive the latest legal developments, insights and news from Ashurst.  By signing up, you agree to receive commercial messages from us.  You may unsubscribe at any time.

Sign up

Ashurst LLP, New York, NY, is responsible for content in the US.

Get Started

        Forgot Password - Ashurst Account

        If you have forgotten your password, you can request a new one here.


        Forgot password? Please contact your relationship manager to find out more about our client portal.
        Ashurst Loader